![]() |
talk at upcoming 2011 AACR annual meeting--her2 bc prevention..in mice
only brief treatment needed during just the right time, it seems!!!
2838 Brief exposure to gefitinib/Iressa during premalignant risk window provides lifelong protection from mammary tumor development in MMTV-erbB-2 transgenic mice. Zhikun Ma, Yunbo Jiang, Shihe Yang, Stanley D. Kosanke, Xiaoshan Feng, XiaoHe Yang. |
| All times are GMT -7. The time now is 04:03 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021